Mar 2024 $5 M No. 6 $2 to $10 million 5
Emerging Therapy Solutions, Inc.: Raise no. 6, Mar 2024 × Investors in this round 5 investors had bought by the notice of Mar 26, 2024: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ashley Hume · Executive Officer Kevin Roche · Executive Officer, Director Nathan Schmidt · Executive Officer Gary Matthew Curtis · Director J. Matthew Mackowski · Director Larry Matthew Kocot · Director Mike Matthew Burke · Director Ravi Matthew Nalliah · Director Rob Matthew Capone · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Nate Schmidt, Chief Financial and Administrative Officer. Source: SEC Form D, newest notice filed Mar 26, 2024. Read the notice at the SEC .
equity SEC Dec 2022 $3 M No. 5 $2 to $10 million 5
Emerging Therapy Solutions, Inc.: Raise no. 5, Dec 2022 × Investors in this round 5 investors had bought by the notice of Dec 20, 2022: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David McLean · Executive Officer, Director Kevin Roche · Executive Officer, Director Gary Matthew Curtis · Director J. Matthew Mackowski · Director Mike Matthew Burke · Director Ravi Matthew Naliah · Director Rob Matthew Capone · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David McLean, Ceo. Source: SEC Form D, newest notice filed Dec 20, 2022. Read the notice at the SEC .
equity SEC Jun 2021 $6 M No. 4 $2 to $10 million 5
Emerging Therapy Solutions, Inc.: Raise no. 4, Jun 2021 × Investors in this round 5 investors had bought by the notice of Jun 7, 2021: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David McLean · Executive Officer, Director Kevin Roche · Executive Officer, Director J. Matthew Mackowski · Director Jeanette Matthew Welsh · Director Ravi Matthew Nalliah · Director Steve Matthew Lefar · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David McLean, Ceo. Source: SEC Form D, newest notice filed Jun 7, 2021. Read the notice at the SEC .
equity SEC Feb 2020 $3 M No. 3 $2 to $10 million 5
Emerging Therapy Solutions, Inc.: Raise no. 3, Feb 2020 × Investors in this round 5 investors had bought by the notice of Feb 18, 2020: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David McLean · Executive Officer, Director Kevin Roche · Executive Officer, Director J. Matthew Mackowski · Director Jeanette Matthew Welsh · Director Ravi Matthew Nalliah · Director Steve Matthew Lefar · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David McLean, Ceo. Source: SEC Form D, newest notice filed Feb 18, 2020. Read the notice at the SEC .
equity SEC May 2019 $1 M No. 2 Under $2 million 1
Emerging Therapy Solutions, Inc.: Raise no. 2, May 2019 × Investors in this round 1 investor had bought by the notice of May 22, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David McLean · Executive Officer, Director Kevin Roche · Executive Officer, Director Jeanette Welsh · Director Matt Mackowski · Director Ravi Nalliah · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David McLean, Ceo. Source: SEC Form D, newest notice filed May 22, 2019. Read the notice at the SEC .
equity SEC Dec 2018 $5 M No. 1 $2 to $10 million 4
Emerging Therapy Solutions, Inc.: Raise no. 1, Dec 2018 × Investors in this round 4 investors had bought by the notice of Jan 4, 2019: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David McLean · Executive Officer, Director Kevin Roche · Executive Officer, Director Jeanette Welsh · Director Matt Mackowski · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David McLean, Ceo. Source: SEC Form D, newest notice filed Jan 4, 2019. Read the notice at the SEC .
equity SEC